Pete Dayananda - JoVE Visualize

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Policies

Filters

Pete Dayananda

Showing results (11-20 of 13) with videos related to

Pageof 2

Sort By:

You have reached the last page of results.This site can display upto 13 results.

Npj Drug Discovery|June 30, 2026

Intranasal monoclonal antibodies do not prevent respiratory infection in a randomized, controlled experimental infection trialJonne Terstappen, Elisabeth E Nibbelke, Stephanie Ascough, et al.

Nature Medicine|July 1, 2026

Innate immune responsiveness predicts enhanced cellular immunity and symptomatic disease after controlled human influenza infectionLoukas Papargyris, Jiayun Xu, Claire Broderick, et al.

Nature Communications|November 30, 2024

SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infectionsJoshua Rosenheim, Rishi K Gupta, Clare Thakker, et al.

Pageof 2

Search research articles

Showing results (11-20 of 13) with videos related to

Sort By:

Pageof 2

You have reached the last page of results.This site can display upto 13 results.

Npj Drug Discovery|June 30, 2026

Intranasal monoclonal antibodies do not prevent respiratory infection in a randomized, controlled experimental infection trialJonne Terstappen, Elisabeth E Nibbelke, Stephanie Ascough, et al.

Nature Medicine|July 1, 2026

Innate immune responsiveness predicts enhanced cellular immunity and symptomatic disease after controlled human influenza infectionLoukas Papargyris, Jiayun Xu, Claire Broderick, et al.

Nature Communications|November 30, 2024

SARS-CoV-2 human challenge reveals biomarkers that discriminate early and late phases of respiratory viral infectionsJoshua Rosenheim, Rishi K Gupta, Clare Thakker, et al.

Pageof 2